Lee, Danner & Bass’s Simplify Health Care ETF PINK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.57M Buy
165,477
+4,825
+3% +$172K 0.35% 63
2025
Q4
$5.88M Buy
160,652
+9,850
+7% +$345K 0.42% 53
2025
Q3
$4.78M Buy
150,802
+3,240
+2% +$98K 0.35% 64
2025
Q2
$4.43M Hold
147,562
0.34% 64
2025
Q1
$4.33M Sell
147,562
-1,218
-0.8% -$36.5K 0.35% 63
2024
Q4
$4.41M Buy
148,780
+1,410
+1% +$44.4K 0.35% 61
2024
Q3
$4.84M Buy
147,370
+8,287
+6% +$267K 0.34% 59
2024
Q2
$4.37M Buy
+139,083
New +$4.16M 0.34% 62
2023
Q4
$3.49M Sell
127,693
-800
-0.6% -$20.1K 0.3% 78
2023
Q3
$3.23M Sell
128,493
-1,065
-0.8% -$27.9K 0.29% 77
2023
Q2
$3.44M Buy
129,558
+9,875
+8% +$255K 0.3% 73
2023
Q1
$3M Sell
119,683
-1,185
-1% -$30K 0.28% 78
2022
Q4
$3.21M Buy
120,868
+7,340
+6% +$190K 0.3% 73
2022
Q3
$2.7M Buy
+113,528
New +$2.86M 0.29% 77

Other funds holding PINK

Lee, Danner & Bass's PINK Position: Q1 2026 in Review

Lee, Danner & Bass increased its Simplify Health Care ETF (PINK) stake by 3% in Q1 2026, buying an estimated $172K and bringing the position to 165,477 shares worth $5.57M. The position accounts for 0.35% of the portfolio, ranked #63.

Lee, Danner & Bass first reported a position in PINK in Q3 2022 and has held it in 14 quarters since. The position peaked at $5.88M in Q4 2025. 61 funds tracked by Wall St. Rank hold PINK as of Q1 2026.

  • Lee, Danner & Bass held 165,477 shares of Simplify Health Care ETF worth $5.57M as of Q1 2026.
  • Lee, Danner & Bass bought 4,825 Simplify Health Care ETF shares in Q1 2026, an estimated $172K.
  • Simplify Health Care ETF made up 0.35% of Lee, Danner & Bass's portfolio in Q1 2026, its #63 holding.
  • Lee, Danner & Bass first reported a position in Simplify Health Care ETF in Q3 2022 and has held it in 14 quarters since.
  • Lee, Danner & Bass's Simplify Health Care ETF position peaked at $5.88M in Q4 2025.
  • 61 funds tracked by Wall St. Rank held Simplify Health Care ETF as of Q1 2026.

Based on Lee, Danner & Bass's 13F filing for Q1 2026, filed 28 Apr 2026.